310 related articles for article (PubMed ID: 20100344)
1. Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.
Zhang XY; Kutner RH; Bialkowska A; Marino MP; Klimstra WB; Reiser J
Retrovirology; 2010 Jan; 7():3. PubMed ID: 20100344
[TBL] [Abstract][Full Text] [Related]
2. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.
Aires da Silva F; Costa MJ; Corte-Real S; Goncalves J
Hum Gene Ther; 2005 Feb; 16(2):223-34. PubMed ID: 15761262
[TBL] [Abstract][Full Text] [Related]
3. Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types.
Kasaraneni N; Chamoun-Emanuelli AM; Wright G; Chen Z
mBio; 2017 Dec; 8(6):. PubMed ID: 29233896
[TBL] [Abstract][Full Text] [Related]
4. Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins.
Lee CL; Dang J; Joo KI; Wang P
Virus Res; 2011 Sep; 160(1-2):340-50. PubMed ID: 21802459
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.
Schauber CA; Tuerk MJ; Pacheco CD; Escarpe PA; Veres G
Gene Ther; 2004 Feb; 11(3):266-75. PubMed ID: 14737086
[TBL] [Abstract][Full Text] [Related]
6. Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins.
Morizono K; Ku A; Xie Y; Harui A; Kung SK; Roth MD; Lee B; Chen IS
J Virol; 2010 Jul; 84(14):6923-34. PubMed ID: 20484510
[TBL] [Abstract][Full Text] [Related]
7. Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells.
Trobridge GD; Wu RA; Hansen M; Ironside C; Watts KL; Olsen P; Beard BC; Kiem HP
Mol Ther; 2010 Apr; 18(4):725-33. PubMed ID: 19997089
[TBL] [Abstract][Full Text] [Related]
8. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
9. Pseudotyped Lentiviral Vectors: One Vector, Many Guises.
Joglekar AV; Sandoval S
Hum Gene Ther Methods; 2017 Dec; 28(6):291-301. PubMed ID: 28870117
[TBL] [Abstract][Full Text] [Related]
10. Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.
Mendenhall A; Lesnik J; Mukherjee C; Antes T; Sengupta R
J Vis Exp; 2012 Apr; (62):e3171. PubMed ID: 22508377
[TBL] [Abstract][Full Text] [Related]
11. Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
Kneissl S; Abel T; Rasbach A; Brynza J; Schneider-Schaulies J; Buchholz CJ
PLoS One; 2012; 7(10):e46667. PubMed ID: 23071609
[TBL] [Abstract][Full Text] [Related]
12. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
Zhang XY; La Russa VF; Reiser J
J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277
[TBL] [Abstract][Full Text] [Related]
13. Efficient transduction of equine adipose-derived mesenchymal stem cells by VSV-G pseudotyped lentiviral vectors.
Petersen GF; Hilbert B; Trope G; Kalle W; Strappe P
Res Vet Sci; 2014 Dec; 97(3):616-22. PubMed ID: 25443656
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule.
Froelich S; Ziegler L; Stroup K; Wang P
Biotechnol Bioeng; 2009 Sep; 104(1):206-15. PubMed ID: 19452500
[TBL] [Abstract][Full Text] [Related]
15. Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.
Anastasov N; Höfig I; Mall S; Krackhardt AM; Thirion C
Methods Mol Biol; 2016; 1448():49-61. PubMed ID: 27317172
[TBL] [Abstract][Full Text] [Related]
16. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.
Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X
Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624
[TBL] [Abstract][Full Text] [Related]
17. Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein.
Sakuma T; De Ravin SS; Tonne JM; Thatava T; Ohmine S; Takeuchi Y; Malech HL; Ikeda Y
Hum Gene Ther; 2010 Dec; 21(12):1665-73. PubMed ID: 20507233
[TBL] [Abstract][Full Text] [Related]
18. Targeting lentiviral vector to specific cell types through surface displayed single chain antibody and fusogenic molecule.
Lei Y; Joo KI; Zarzar J; Wong C; Wang P
Virol J; 2010 Feb; 7():35. PubMed ID: 20149250
[TBL] [Abstract][Full Text] [Related]
19. Altering the tropism of lentiviral vectors through pseudotyping.
Cronin J; Zhang XY; Reiser J
Curr Gene Ther; 2005 Aug; 5(4):387-98. PubMed ID: 16101513
[TBL] [Abstract][Full Text] [Related]
20. The Engineered MARCH8-Resistant Vesicular Stomatitis Virus Glycoprotein Enhances Lentiviral Vector Transduction.
Xu F; Liu X; Zhang D; Zhao F; Fan Z; Hu S; Mei S; Huang Y; Sun H; Wei L; Guo L; Wang J; Cen S; Liang C; Guo F
Hum Gene Ther; 2021 Sep; 32(17-18):936-948. PubMed ID: 33678011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
